Orchid Pharma receives EIR from US FDA
The approval was received on successful inspection closure of its Irungattukottai formulations plant in Tamil Nadu
Orchid Pharma…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
GVK Biosciences row: India, EU to meet on Jan 18 in Brussels
Upcoming Brussels meet between India, EU to look at the ban on around 700 pharma products which were clinically tested by…
Cadila Healthcare receives warning letter from US FDA
The letters were received for its two facilities in Gujarat
Cadila Healthcare has received a warning letter from the US Food and…
Dr Harsh Vardhan unveils National Biotechnology Development Strategy 2015-2020
The strategy developed by the Department of Biotechnology aims to turn India's biotech sector into a $100 billion industry by 2025…
Huvepharma to acquire certain assets from Zoetis
The company will also acquire and assume manufacturing sites in the US located in Laurinburg, North Carolina and Van Buren,…
No respite for Big Pharma on patents
Dilution of Section 3(d), compulsory licensing unlikely despite US concerns
Disappointed with India’s new National IPR Policy,…
Madras HC stays prosecution over multidose diclofenac
Issuing a notice to the Union Health Ministry, the bench directed it to file counter affidavit within four weeks
The Madras High…
Dengvaxia first dengue vaccine approved in Brazil
With 1.4 million dengue cases reported this year, Brazil stands to gain tremendous value from this new dengue prevention tool…
Suven Life gets patent for neurodegenerative drug
The patents are valid through 2030 and 2029
Suven Life Sciences has been granted a patent each by Europe and Macau for drug used…
India’s pharma industry may touch $55 bn by 2020: Report
Exports from the sector may slow down to grow at a CAGR of 7.98 per cent owing to stricter regulations in markets such as the US,…